NeuroLife technology is designed to support applications across rehabilitation, neuromuscular analytics and future neuro-enabled solutions.
NeuroLife has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in June 2026.
NeuroLife's investors include The NeuroTech Institute, Battelle.
NeuroLife is headquartered in Columbus, United States.
NeuroLife technology is designed to support applications across rehabilitation, neuromuscular analytics and future neuro-enabled solutions.
NeuroLife is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroLife — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/neurolife. Accessed August 23, 2026.
VCBacked. (2026). NeuroLife — Funding & Investors. Retrieved August 23, 2026, from https://www.vcbacked.co/company/neurolife
{{cite web |title=NeuroLife — Funding & Investors |url=https://www.vcbacked.co/company/neurolife |website=VCBacked |access-date=August 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated